TQ Course | Challenging and Controversial Topics in Glaucoma (12/20/20) by Optometric Education Consultants | Dec 12, 2020 | TQ Courses | 0 comments HiddenDate (Hidden) MM slash DD slash YYYY 1. Which of the following is a nitric oxide donating prostaglandin?* A - Rocklatan B - Zioptan C - Rhopressa D - Vyzulta 2. Which of the following is a rho-kinase/prostaglandin combination?* A - Rocklatan B - DuoTrav C - Rhopressa D - Vyzulta 3. Which of the following is a solo rho-kinase inhibitor?* A - Rocklatan B - DuoTrav C - Rhopressa D - Vyzulta 4. What term refers to a relatively small visual field abnormality in the nerve fiber bundle region that is generally not contiguous with the blind spot or the nasal meridian and does not involve points outside 15 degrees that are adjacent to the nasal meridian?* A - Arcuate defect B - Central scotoma C - Nasal step D - Paracentral scotoma 5. What term refers to visual field loss that is predominantly in the macular region with the foveal threshold having a p < 5% value?* A - Arcuate defect B - Central scotoma C - Nasal step D - Paracentral scotoma 6. Which of the following ways is not typical of visual field progression?* A - Deepening of an existing defect B - Extension of an existing defect C - A decrease in short term fluctuation D - Development of a new defect in previously normal area 7. In regard to static perimetry, what value would be outside human vision?* A - 5 db B - 25db C - 33 db D - 45 db 8. Normal visual field parameters extend to what degree superiorly?* A - 60 degrees B - 13 degrees C - 100 degrees D - 75 degrees 9. A 10-2 Humphrey visual field tests how many points?* A - 54 points B - 76 points C - 30 points D - 68 points 10. Which visual field concept looks at the significance of rate of change over time?* A - Trend analysis B - Event analysis C - Progression analysis D - Visual field index 11. Which visual field concept compares baseline to most recent data?* A - Trend analysis B - Event analysis C - Progression analysis D - Visual field index 12. Where on the optic disc is a glaucomatous hemorrhage least likely to occur?* A - Nasal B - Superior C - Inferior temporal D - Inferior 13. In the OHTS study, the occurrence of a disc hemorrhage increased the risk of developing POAG by how much in a univariate analysis?* A - Double B - Four-fold C - Six fold D - Eight fold 14. How many mechanisms of action does netarsudil (Rhopressa) purport to have?* A - One B - Two C - Three D - Four 15. How many mechanisms of action does netarsudil/latanoprost (Rocklatan) purport to have?* A - One B - Two C - Three D - Four 16. Which medication has been noted to cause vortex keratopathy?* A - Vyzulta B - Rocklatan C - Latanoprost D - Tafluprost 17. According to OHTS, what was the most sensitive method for identifying optic disc hemorrhages?* A - Optic disc photography B - Clinical examination with a non-contact fundus lens C - Widefield imaging D - Optical coherence tomography 18. Which major glaucoma study indicated that optic disc hemorrhages do not occur in every glaucoma patient?* A - Ocular Hypertension Treatment Study B - Early Manifest Glaucoma Trial C - Advanced Glaucoma Intervention Study D - Collaborative Normal Tension Glaucoma Study 19. According to the best available evidence, what is the most likely underlying pathophysiology of an optic disc hemorrhage in glaucoma?* A - An apoptotic event B - An ischemic event C - A mechanical shifting of tissues D - An abnormality in collagen vascular tissue 20. When initially setting a target pressure for a patient with glaucoma, which of the following is not a typical consideration?* A - Patient age and life expectancy B - Extent of field damage C - Insurance coverage of medications and surgery D - Peak IOP Personal InformationName* First Last Email* Phone*OE Tracker # License # Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongo, Democratic Republic of theCongo, Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatini (Swaziland)EthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacauMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth GeorgiaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan Mayen IslandsSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaVietnamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationHiddenRetake Code Challenging and Controversial Topics in Glaucoma | TQ Credit*After 2/18/2021, pricing will increase to $30. Price: (Past 60 Days) Evolving Trends in Retinal Vascular Disease | TQ Credit Price: This course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30.Retake Discount Price: (Past 60 Days) Retake Discount Price: Payment Method*Please note, the charge on your card statement will appear from WeyesGeyes, not Optometric Education Consultants. WeyesGeyes is the LLC that Optometric Education Consultants does business under.Credit Card American ExpressDiscoverMasterCardVisaSupported Credit Cards: American Express, Discover, MasterCard, Visa Card Number Card Number Expiration Date Expiration Date Security Code Security Code Cardholder Name HiddenCourse Information (HIDDEN)HiddenCourse Name (HIDDEN) HiddenCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
